Sarah AuclairScientist at Sanofi
Dr. Sarah Auclair has more than 15 years of experience characterizing proteins and studying the relationship between protein structure and function. She is currently a scientist at Sanofi in the Developability and Preformulation Sciences group within Biologics Drug Product Development. Sarah leads and supports early stage development for Sanofi’s exciting pipeline of biologics. She holds a PhD in Molecular Biology and Biochemistry from Wesleyan University and has competed postdoctoral research at the University of Connecticut in Pharmaceutical Sciences and at Yale University in the Nanobiology Institute.